You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for FEXOFENADINE HYDROCHLORIDE ALLERGY


✉ Email this page to a colleague

« Back to Dashboard


FEXOFENADINE HYDROCHLORIDE ALLERGY

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo Pharma Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 202039 ANDA 7-eleven 10202-229-66 1 BLISTER PACK in 1 CARTON (10202-229-66) / 10 TABLET, FILM COATED in 1 BLISTER PACK 2015-01-15
Aurobindo Pharma Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 202039 ANDA Aphena Pharma Solutions - Tennessee, LLC 71610-292-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-292-30) 2015-01-15
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076502 ANDA Walgreens Company 0363-0783-24 4 BLISTER PACK in 1 CARTON (0363-0783-24) / 6 TABLET in 1 BLISTER PACK 2020-12-14
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076502 ANDA Walgreens Company 0363-0784-07 1 BLISTER PACK in 1 CARTON (0363-0784-07) / 5 TABLET in 1 BLISTER PACK 2011-04-13
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076502 ANDA Walgreens Company 0363-0784-15 1 BOTTLE in 1 CARTON (0363-0784-15) / 150 TABLET in 1 BOTTLE 2011-04-13
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Fexofenadine Hydrochloride (Allergy)

Last updated: August 8, 2025

Introduction: Overview of Fexofenadine Hydrochloride

Fexofenadine Hydrochloride is an antihistamine used primarily to treat allergic rhinitis and chronic urticaria. It is a second-generation non-sedating antihistamine, offering efficacy with minimal sedative effects. As demand for allergy medications rises globally, sourcing high-quality fexofenadine hydrochloride from reputable suppliers becomes critical for pharmaceutical companies, Distributors, and healthcare providers.

Market Overview and Demand Dynamics

The global allergy medication market is projected to grow at a compound annual growth rate (CAGR) of approximately 5% from 2022 to 2030, driven by increased allergy awareness, urbanization, and environmental factors. Fexofenadine is among the top-selling antihistamines, with key formulations in tablets, orally disintegrating tablets, and liquid suspensions (Market Research Future, 2021). Ensuring reliable supply chains for API (Active Pharmaceutical Ingredient) and finished products is necessary to meet projected demand effectively.

Major Suppliers of Fexofenadine Hydrochloride API

1. Teva Pharmaceutical Industries Ltd.

  • Overview: Israeli multinational pharmaceutical company and the world's largest generic drug manufacturer.
  • API Supply: Teva produces fexofenadine hydrochloride API, adhering to strict GMP standards.
  • Strengths: Extensive global distribution network, consistent quality, and a broad portfolio of allergy medications.
  • Certifications: ISO 9001, GMP certifications for manufacturing facilities.

2. Jiangsu Hengrui Medicine Co., Ltd.

  • Overview: Leading Chinese pharmaceutical firm with a focus on innovative and generic drugs.
  • API Supply: Offers high-grade fexofenadine hydrochloride API, compliant with international standards.
  • Certifications: GMP, ISO 9001, and Good Clinical Practice (GCP).

3. Mylan N.V. (Now part of Viatris Inc.)

  • Overview: Global pharmaceutical corporation known for its extensive generic product portfolio.
  • API & Finished Dosage: Supplies fexofenadine hydrochloride API as well as finished tablets.
  • Market Reach: Strong presence in North America and Europe.

4. Alkem Laboratories

  • Overview: Indian pharmaceutical leader specializing in generics and APIs.
  • API Manufacturing: Produces high-quality fexofenadine hydrochloride API for domestic and export markets.
  • Certifications: WHO-GMP compliant manufacturing facilities.

5. Zhejiang Huahai Pharmaceutical Co., Ltd.

  • Overview: Chinese pharmaceutical company with a focus on APIs, including antihistamines.
  • API Production: Significant capacity for fexofenadine hydrochloride API.
  • Standards: GMP certification and strict quality control.

Key Manufacturers in Southeast Asia and India

  • Torrent Pharmaceuticals: Provides APIs and formulations, focusing on affordability and quality.
  • Aurobindo Pharma: Large-scale API manufacturer with a growing portfolio in antihistamines.
  • Sun Pharmaceutical Industries: Offers high-quality API, including fexofenadine hydrochloride.

Reputable Suppliers of Finished Fexofenadine Formulations

For companies seeking ready-to-market allergy medications, several suppliers offer finished formulations:

  • Mylan / Viatris: Marketed under brand names like Allegra, Telfast.
  • Sanofi: Distributes formulations across various regions.
  • Dr. Reddy’s Laboratories: Provides generic fexofenadine tablets.

Supply Chain Considerations and Regulatory Compliance

When selecting suppliers, ensure compliance with regulatory frameworks such as the FDA (U.S.), EMA (Europe), and PMDA (Japan). Key factors include:

  • GMP Certification: Ensures quality and manufacturing standards.
  • Audits and Inspections: Regular third-party audits verify compliance.
  • Traceability: Transparent supply chain documentation.
  • Capacity & Scalability: Ability to meet demand fluctuations.

Emerging Trends and Future Outlook

The API market for fexofenadine hydrochloride is evolving, with manufacturers investing in sustainable and advanced manufacturing processes. The rise of biosimilars and increased focus on cost-effective generics enhances supplier competition. Strategic partnerships, licensing agreements, and alliances with contract manufacturing organizations (CMOs) are enabling faster market entry.

Conclusion

Securing reliable suppliers for fexofenadine hydrochloride involves evaluating the manufacturer’s quality standards, regulatory compliance, capacity, and distribution capabilities. Leading global players like Teva, Mylan (Viatris), and Chinese giants such as Jiangsu Hengrui dominate the API market. Indian companies, including Aurobindo and Sun Pharma, also play significant roles. As demand grows, diversifying supplier portfolios and maintaining stringent quality control remain key to establishing resilient supply chains.

Key Takeaways

  • The global demand for fexofenadine hydrochloride continues to rise, driven by increasing prevalence of allergies.
  • Leading API manufacturers include Teva, Jiangsu Hengrui, Mylan (Viatris), and Indian firms like Aurobindo and Sun Pharma.
  • Ensuring suppliers meet international GMP standards, possess robust traceability, and demonstrate capacity is vital.
  • Consider regional supplier capabilities and compliance certifications to meet regulatory requirements.
  • Diversification of supply sources mitigates risks and enhances supply chain robustness.

FAQs

Q1. What are the major regions supplying fexofenadine hydrochloride API?
Most APIs originate from North America (Teva), China (Jiangsu Hengrui, Zhejiang Huahai), and India (Aurobindo, Sun Pharma). Southeast Asian suppliers are emerging with increasing capacity.

Q2. How can I verify if a supplier complies with regulatory standards?
Request GMP certifications, audit reports, and comparable third-party validations. Regulatory authorities like the FDA or EMA also verify compliance during site inspections.

Q3. Are branded formulations available from multiple suppliers?
Yes. Companies like Mylan (Viatris), Sanofi, and Dr. Reddy’s distribute branded formulations globally, often sourced from various manufacturing sites.

Q4. What are key considerations when selecting a fexofenadine hydrochloride API supplier?
Quality standards, regulatory compliance, manufacturing capacity, lead times, costs, and traceability are crucial factors.

Q5. Is there a trend towards sustainable manufacturing for APIs like fexofenadine hydrochloride?
Yes. Increasing emphasis on environmental sustainability prompts suppliers to adopt green chemistry practices and reduce carbon footprints in API production.


Sources:
[1] Market Research Future. (2021). "Global Antihistamines Market."
[2] IQVIA. (2022). "Pharmaceutical Market Data."
[3] GlobalData. (2022). "API Industry Analysis."

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.